FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1217-1218 October 18, 2001 Number 16

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Henry R. Black. 643 pp. New York, Marcel Dekker, 2001. $225. ISBN 0-8247-0270-0.

One of the highlights among the remarkable achievements in medicine over the past four decades has been the development of antihypertensive agents. Since the introduction of these agents into clinical practice, cardiovascular mortality in this country has been reduced from a rate above 54 percent to a rate below 50 percent, an astounding and impressive statistic. This reduction in the overall rate of death due to cardiovascular causes can be attributed primarily to a reduction of more than 70 percent in the rate of death due to stroke and a reduction of more than 50 percent in the rate of . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.